Showing results (3121-3130 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 27, 2012
Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockersSatoshi Imaizumi, Shin-ichiro Miura, Eiji Yahiro, et al.Current Pharmaceutical Design|April 12, 2002
Biological and clinical significance of endotoxemia in the course of hepatitis C virus infectionL Caradonna, M L Mastronardi, T Magrone, et al.Current Pharmaceutical Design|April 12, 2002
COX selectivity and animal models for colon cancerMasanobu Oshima, Makoto M TaketoCurrent Pharmaceutical Design|April 12, 2002
Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol)Garry G Graham, Robert I Graham, Richard O DayCurrent Pharmaceutical Design|April 12, 2002
The peptidase zymogen proregions: nature's way of preventing undesired activation and proteolysisClaude LazureCurrent Pharmaceutical Design|April 12, 2002
Peptide and non-peptide HIV fusion inhibitorsShibo Jiang, Qian Zhao, Asim K DebnathCurrent Pharmaceutical Design|April 12, 2002
Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model moleculesHisham R Ibrahim, Takayoshi Aoki, Antonio PellegriniCurrent Pharmaceutical Design|April 12, 2002
From innate immunity to de-novo designed antimicrobial peptidesYechiel ShaiCurrent Pharmaceutical Design|April 12, 2002
Molecular diversity in gene-encoded, cationic antimicrobial polypeptidesA Tossi, L SandriPageof 1,008